Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICS-associated pneumonia mechanism study in severe COPD
2016-000734-21Phase 4Terminated
- Sponsor
- University of Dundee
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fluticasone propionate, salmeterol, budesonide and formoterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University of Dundee. Primary endpoint: Upper airway total respiratory pathogen bacterial load. Started Aug 2016; status: terminated.
02
Drugs
fluticasone propionatesalmeterolbudesonideformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2016-000734-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000734-21.